Group One Trading’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,600
Closed -$5K 7365
2022
Q3
$5K Hold
3,600
﹤0.01% 6820
2022
Q2
$8K Buy
3,600
+2,800
+350% +$6.43K ﹤0.01% 6866
2022
Q1
$3K Hold
800
﹤0.01% 7613
2021
Q4
$3K Sell
800
-1,500
-65% -$8.42K ﹤0.01% 7766
2021
Q3
$19K Sell
2,300
-8,600
-79% -$69.9K ﹤0.01% 7198
2021
Q2
$82K Buy
10,900
+8,400
+336% +$70.8K ﹤0.01% 6145
2021
Q1
$22K Buy
+2,500
New +$23.8K ﹤0.01% 6716
2020
Q3
Sell
-1,000
Closed -$10K 6146
2020
Q2
$10K Sell
1,000
-4,000
-80% -$36.7K ﹤0.01% 5117
2020
Q1
$39K Buy
+5,000
New +$25.2K ﹤0.01% 3874
2018
Q2
Sell
-1,100
Closed -$8K 5153
2018
Q1
$8K Sell
1,100
-5,300
-83% -$40.1K ﹤0.01% 4377
2017
Q4
$42K Buy
6,400
+2,400
+60% +$15.3K ﹤0.01% 3819
2017
Q3
$25K Buy
+4,000
New +$20.4K ﹤0.01% 3959
2016
Q4
Sell
-400
Closed -$3K 4472
2016
Q3
$3K Buy
+400
New +$2.08K ﹤0.01% 4291
2015
Q3
Sell
-300
Closed -$2K 4910
2015
Q2
$2K Buy
+300
New +$2.04K ﹤0.01% 4659

Other funds holding CTSO

Group One Trading's CTSO Position: Q3 2023 in Review

Group One Trading sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 4,263 shares — an estimated $12.2K sold.

Group One Trading first reported a position in CTSO in Q3 2016 and held it in 18 quarters. The position peaked at $117K in Q2 2018. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.

  • Group One Trading reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 4,263 Cytosorbents Corp shares in Q3 2023, an estimated $12.2K.
  • Group One Trading first reported a position in Cytosorbents Corp in Q3 2016 and held it in 18 quarters.
  • Group One Trading's Cytosorbents Corp position peaked at $117K in Q2 2018.
  • 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.